Drugs / Dimethicone
Dimethicone
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01914627 | Aug 2013 → Jan 2014 | psoriasis | G. Pohl-Boskamp GmbH & Co. KG | Completed | No outcome recorded |
| Phase 2 | NCT02213055 | May 2009 → Aug 2014 | Pediculus humanus capitis infestation | Hackensack Meridian Health | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02299206 | Dec 2014 → Jul 2016 | infantile miliaria | Northwestern University | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT06713421 Comparator | Dec 2024 → Sep 2025 overdue | esophageal cancer, gastric cancer | Changhai Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dimethicone | “CeraVe Baby Diaper Rash Cream (ingredients: Zinc oxide 10mg in 1g (1%) and dimethicone 10mg in 1g)” NCT02299206 ↗ |
| Known as | Generic Name: Dimethicone | “Generic Name: Dimethicone” NCT02213055 ↗ |
| Known as | Loion | “a topical dimeticone formulation (Loion®)” NCT01914627 ↗ |
| Route | Topical | “a topical dimeticone formulation” NCT01914627 ↗ |